A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)
Public ClinicalTrials.gov record NCT00109564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this Phase II study is to evaluate the efficacy and safety of ispronicline (TC-1734-112) compared to placebo (inactive substance pill) in patients with age associated memory impairment (AAMI). AAMI is characterized as cognitive impairment including memory loss and poor concentration associated with aging.
Study identification
- NCT ID
- NCT00109564
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 174 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2005 (Type not available)
- Last update posted
- Jul 18, 2008
2005
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pivotal Research Center | Mesa | Arizona | 85210 | — |
| Pivotal Research Center | Peoria | Arizona | 85381 | — |
| Radiant Research | Denver | Colorado | 80212 | — |
| Neuropsychiatric Research Center of SW Florida | Fort Meyers | Florida | 33912 | — |
| Meridien Research | Saint Petersberg | Florida | 33709 | — |
| Meridien Research | Tampa | Florida | 33609 | — |
| Northlake Medical Research Center | Decatur | Georgia | 30033 | — |
| Hartford Research | Florence | Kentucky | 41042 | — |
| Berman Center | Minneapolis | Minnesota | 55404 | — |
| Radiant Research | St Louis | Missouri | 63141 | — |
| Kulynych Research Center | Greensboro | North Carolina | 27408 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Radiant Research Philadelphia | Philadelphia | Pennsylvania | 19115 | — |
| Radiant Research | San Antonio | Texas | 78229 | — |
| Radiant Research | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00109564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2008 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00109564 live on ClinicalTrials.gov.